$Uniqure(QURE.US) | Barclays reiterates ๐๐ช๐ฎ๐๐ฅ๐ฐ๐๐ข๐ ๐ก๐ญ on ๐ฎ๐ง๐ข๐๐ฎ๐ซ๐, maintains ๐๐ ๐๐ญ $๐๐
Analyst sees FDA's positive feedback on the BLA pathway for AMT-130 in Huntington's as a major positive, potentially implying meaningful upside.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments